# Everolimus

## Afinitor 5mg

##### 臨採

| TAH Drug Code      | [OAFI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OAFI)                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of postmenopausal women w/ advanced hormone receptor positive & HER-2 negative breast cancer in combination w/ exemestane after failure of treatment w/ letrozole or anastrozole. Progressive neuroendocrine tumors of pancreatic origin (PNET) w/ unresectable, locally advanced or metastatic disease. Advanced renal cell carcinoma (RCC) after failure of treatment w/ sunitinib or sorafenib. |
| Dosing             | [Advanced Breast cancer, hormone receptor-positive, HER2-negative; Advanced Neuroendocrine tumors (GI, lung, or pancreatic origin); Advanced Renal cell cancer (RCC)] 10 mg orally once daily, continue treatment until disease progression or unacceptable toxicity                                                                                                                                         |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Hypersensitivity to everolimus or other rapamycin derivatives.                                                                                                                                                                                                                                                                                                                                               |
| Adverse Effects    | Stomatitis, infections, rash, fatigue, diarrhea, decreased appetite, hyperglycemia, dyspnea, pneumonitis, hypercholesterolemia, increased AST & ALT, anemia, leukopenia, thrombocytopenia, lymphopenia, hypertriglyceridemia, decreased K.                                                                                                                                                                   |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                              |

